Caption Management, LLC Innoviva, Inc. Put Options Transaction History

Caption Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $853,025 - $1.04 Million	74,500 New	74,500 $998,000
Q1 2021 May 17, 2021	SELL	$11.06 - $12.87 $553,000 - $643,500	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $466,500 - $624,000	50,000 New	50,000 $621,000
Q3 2020 Nov 16, 2020	SELL	$10.33 - $14.49 $3.62 Million - $5.07 Million	-350,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $1.15 Million - $1.53 Million	-100,000 Reduced 22.22%	350,000 $4.89 Million
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $2.43 Million - $4.57 Million	300,000 Added 200.0%	450,000 $5.29 Million
Q4 2019 Feb 13, 2020	SELL	$10.28 - $14.38 $2.68 Million - $3.74 Million	-260,400 Reduced 63.45%	150,000 $2.12 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $4.12 Million - $5.97 Million	410,400 New	410,400 $4.33 Million

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.